Munro Partners Acquires Shares of 120,910 Intuitive Surgical, Inc. $ISRG

Munro Partners bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, Holdings Channel.com reports. The fund bought 120,910 shares of the medical equipment provider’s stock, valued at approximately $65,704,000. Intuitive Surgical makes up 2.1% of Munro Partners’ investment portfolio, making the stock its 21st largest holding.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Aaron Wealth Advisors LLC increased its position in Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares during the period. Evergreen Capital Management LLC lifted its position in Intuitive Surgical by 0.5% during the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after purchasing an additional 20 shares during the period. Rise Advisors LLC boosted its stake in shares of Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after purchasing an additional 20 shares during the last quarter. Pinnacle Bancorp Inc. grew its position in shares of Intuitive Surgical by 4.1% during the 2nd quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after buying an additional 21 shares during the period. Finally, Vertex Planning Partners LLC raised its stake in shares of Intuitive Surgical by 2.3% during the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after buying an additional 21 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on ISRG shares. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, October 21st. The Goldman Sachs Group raised their price target on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Jefferies Financial Group raised their target price on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Finally, Truist Financial set a $620.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $608.79.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 28,800 shares of the business’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the sale, the insider directly owned 27,027 shares of the company’s stock, valued at approximately $14,798,904.12. The trade was a 51.59% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $193,595.79. The trade was a 95.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 109,043 shares of company stock valued at $60,816,225. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Down 0.9%

NASDAQ:ISRG opened at $542.32 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock has a 50-day moving average price of $529.62 and a two-hundred day moving average price of $505.69. The stock has a market cap of $194.41 billion, a price-to-earnings ratio of 71.74, a PEG ratio of 4.98 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the previous year, the business posted $1.84 EPS. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.